Oncology Drug Revenue and Price Negotiation
This Viewpoint examines the potential impacts of the Inflation Reduction Act and negotiation of oncologic drug prices on payments to oncology specialists.
Authors
- Stacie B. Dusetzina (ORCID: https://orcid.org/0000-0002-3907-9196)
- Rachel E. Sachs (ORCID: https://orcid.org/0000-0002-0172-3572)
- Aaron P. Mitchell
Institutions
- Memorial Sloan Kettering Cancer Center (US)
- Washington University in St. Louis (US)
- Vanderbilt University Medical Center (US)
Publication Details
- Journal
- JAMA Oncology
- Published
- 2025-12-26
- DOI
- https://doi.org/10.1001/jamaoncol.2025.5385
- Primary Topic
- Economic and Financial Impacts of Cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00